BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20720453)

  • 1. Modulation of C6 Glioma Cell Proliferation by Ureido-Calix[8]arenes.
    Viola S; Merlo S; Consoli GM; Drago F; Geraci C; Sortino MA
    Pharmacology; 2010; 86(3):182-8. PubMed ID: 20720453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of rat glioma cell migration and proliferation by a calix[8]arene scaffold exposing multiple GlcNAc and ureido functionalities.
    Viola S; Consoli GM; Merlo S; Drago F; Sortino MA; Geraci C
    J Neurochem; 2008 Nov; 107(4):1047-55. PubMed ID: 18778307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.
    Jane EP; Premkumar DR; Pollack IF
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1070-80. PubMed ID: 16959960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses.
    Wu M; Huang C; Li X; Li X; Gan K; Chen Q; Tang Y; Tang K; Shen S; Li G
    J Cell Physiol; 2008 Jan; 214(1):65-74. PubMed ID: 17541939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
    Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
    Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. Part II.
    Latxague L; Gaboriau F; Chassande O; Leger JM; Pires V; Rouge P; Dassonville-Klimpt A; Fardeau S; Jarry C; Lescoat G; Guillon J; Sonnet P
    J Enzyme Inhib Med Chem; 2011 Apr; 26(2):204-15. PubMed ID: 20545489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor progression potential of caffeic acid phenethyl ester involving p75(NTR) in C6 glioma cells.
    Lin WL; Liang WH; Lee YJ; Chuang SK; Tseng TH
    Chem Biol Interact; 2010 Dec; 188(3):607-15. PubMed ID: 20836997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of epidermal growth factor receptor variant III on glioma cell migration by stimulating ERK phosphorylation through the focal adhesion kinase signaling pathway.
    Liu M; Yang Y; Wang C; Sun L; Mei C; Yao W; Liu Y; Shi Y; Qiu S; Fan J; Cai X; Zha X
    Arch Biochem Biophys; 2010 Oct; 502(2):89-95. PubMed ID: 20650261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro.
    Lund-Johansen M; Bjerkvig R; Humphrey PA; Bigner SH; Bigner DD; Laerum OD
    Cancer Res; 1990 Sep; 50(18):6039-44. PubMed ID: 2393868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.
    Tysnes BB; Haugland HK; Bjerkvig R
    Invasion Metastasis; 1997; 17(5):270-80. PubMed ID: 9876221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
    Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
    Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation.
    Noman AS; Koide N; Khuda II; Dagvadorj J; Tumurkhuu G; Naiki Y; Komatsu T; Yoshida T; Yokochi T
    Biochem Biophys Res Commun; 2008 Oct; 374(4):683-7. PubMed ID: 18662673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
    J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathways involved in antioxidant control of glioma cell proliferation.
    Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez-Blanco J; Rodriguez C
    Free Radic Biol Med; 2007 Jun; 42(11):1715-22. PubMed ID: 17462539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
    Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
    Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antroquinonol Targets FAK-Signaling Pathway Suppressed Cell Migration, Invasion, and Tumor Growth of C6 Glioma.
    Thiyagarajan V; Tsai MJ; Weng CF
    PLoS One; 2015; 10(10):e0141285. PubMed ID: 26517117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.